Healthcare ❯ Pharmaceutical Industry

Drug Pricing

Medicare Regulatory Actions Medicare Negotiations Medicaid and Medicare Regulations Medication Prices Eliquis Reforms Insulin Weight-Loss Drugs Inhalers Investigations Import Taxes Cost Reduction Strategies Insurance Negotiations Legislation Patient Access U.S. Market Government Regulation Market Dynamics Supply Chain Management Research Facilities Market Regulations International Trade Government Policies Government Regulations Negotiations Regulatory Issues Generic Drugs NHS Medicare Negotiation Program Negotiation Programs Tariff Implications Price Controls

Pfizer Sets 2026 Targets Below Wall Street as COVID Sales Fade, Patent Pressure Builds

Executives blame weaker COVID demand alongside pending patent losses, signaling a near-term reset toward pipeline investment.

Trump Vows Unachievable 1,400% Drug Price Cuts, Threatens Trade Sanctions